Gateway to Think Tanks
来源类型 | Faculty Working Papers |
规范类型 | 工作论文 |
来源ID | CID Working Paper No. 111 |
Why is There No AIDS Vaccine? | |
Michael Kremer and Christopher M. Snyder | |
发表日期 | 2004-10 |
出版年 | 2004 |
摘要 | We argue that differences in timing of drug and vaccine consumption will lead firms to be biased against developing vaccines. Vaccines are sold before consumers are infected, when they still have private information regarding their infection risk, whereas drugs are sold after consumers are infected, when those with positive valuation have no private information on infection risk. Calibrations suggest that, for sexually transmitted diseases, for which infection risk is highly heterogeneous across consumers, producer surplus from drugs may exceed that from vaccines by a factor of four. Consistent with the model, empirical tests suggest vaccines are particularly unlikely to be developed for sexually transmitted diseases. Biases against vaccines are exacerbated by the durability of vaccines and by the interaction between the timing of vaccine and drug consumption and the temporary protection of intellectual property rights. We extend the analysis to allow for government procurement and for income heterogeneity among consumers. Given that antiretroviral drugs are difficult to deliver in the poor countries where most people infected with HIV/AIDS live, biases against developing a vaccine raise enormous public health concerns. |
URL | https://www.hks.harvard.edu/centers/cid/publications/faculty-working-papers/cid-working-paper-no.-111 |
来源智库 | Center for International Development (United States) |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/503038 |
推荐引用方式 GB/T 7714 | Michael Kremer and Christopher M. Snyder. Why is There No AIDS Vaccine?. 2004. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。